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Abstract In mammals, one of the two X chromosomes of
female cells is inactivated for dosage compensation
between the sexes. X chromosome inactivation is initiated
in early embryos by the noncoding Xist RNA. Subsequent
chromatin modifications on the inactive X chromosome
(Xi) lead to a remarkable stability of gene repression in
somatic cell lineages. In mice, reactivation of genes on the
Xi accompanies the establishment of pluripotent cells of
the female blastocyst and the development of primordial
germ cells. Xi reactivation also occurs when pluripotency
is established during the reprogramming of somatic cells to
induced pluripotent stem cells. The mechanism of Xi
reactivation has attracted increasing interest for studying
changes in epigenetic patterns and for improving methods
of cell reprogramming. Here, we review recent advances in
the understanding of Xi reactivation during development
and reprogramming and illustrate potential clinical
applications.
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Abbreviations
Xic X inactivation center
XCI X chromosome inactivation
Xi Inactive X chromosome
Xa Active X chromosome
PGCs Primordial germ cells
MSCI Meiotic sex chromosome inactivation
Xm Maternally inherited X chromosome
Xp Paternally inherited X chromosome
H3K27me3 Histone H3 tri-methylated on lysine 27
HDAC Histone deacetylase
PcG Polycomb group
H4Ac Acetylated histone H4
5mC 5 methyl cytosine
5hmC 5 hydroxymethyl cytosine
ICM Inner cell mass
ES cells Embryonic stem cells
EC Embryonic carcinoma cells
EpiSCs Epiblast stem cells
iPS cells Induced pluripotent stem cells
EG cells Embryonic germ cells
Introduction
The inactive X chromosome (Xi) was originally observed
as a dense staining structure in the nucleus of female cat
neurons [1]. Since the original observation, the Barr body
has inspired studies and served as a ‘‘visual’’ model for a
silent chromatin state within the mammalian cell nucleus.
Over the last 50 years, the process of X inactivation has
kept its secrets. Although tremendous progress has been
made by a number of laboratories, the mechanism behind
X inactivation in its entirety remains to be worked out. The
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complexity of the overall mechanism, which also involves
pathways that are known to be important for developmental
gene regulation, has captured the attention of a growing
number of scientists. The present text is placed in the
background of a large number of recent review articles that
have discussed the understanding of X inactivation in
detail. We focus here on instances of reactivation of the Xi
in development and cultured cells. This aspect appears to
gain considerable importance as cell reprogramming
requires the erasure of epigenetic patterns. Xi reactivation
has been increasingly used as a model system for under-
standing chromatin changes during reprogramming and
defining the reprogrammed pluripotent cell state. Reacti-
vation of genes on the Xi has also been considered for
ameliorating human genetic diseases caused by mutations
on one of the two X chromosomes in female patients.
Therefore, Xi reactivation is an emerging topic of interest
beyond basic research with potential clinically relevant
applications in the future.
In placental mammals, sex determination relies on the
presence of the SRY gene on the Y chromosome for
specifying male development. Few exceptions are known
in which this sex determination system has evolved fur-
ther by either Y chromosome loss (such as in certain
species of spiny rats [2] and mole voles [3, 4]) or the
evolution of dominant female determining X chromo-
somes (such as in wood lemmings [5]). As a consequence
of male-limited transmission, meiotic recombination of
the mammalian Y chromosome has been restricted and a
large part of Y chromosomal sequences have eroded due
to accumulation of mutations. Recent results analyzing the
sex chromosomes of monotremes indicate that the mam-
malian XY system is relatively young with an estimated
age of less than 166 million years [4, 6]. Notably, mar-
supial mammals share the X chromosome with placental
mammals, whereas sequences of the monotreme sex
chromosomes are unrelated. Importantly, the sequences of
the mammalian X chromosome are identified on auto-
somes in monotremes, thus, providing compelling
evidence that the mammalian XY system was derived
from an ancestral autosome pair before the divergence of
placental and marsupial mammals. An evolutionary origin
closely before mammalian radiation has certain signifi-
cance for explaining mechanistic differences in X
chromosome inactivation (XCI) between mammalian
species that have recently been appreciated. In both pla-
cental and marsupial mammals, the different number of X
chromosomes between the sexes is compensated by
inactivating one of the two X chromosomes in female
cells. This leaves a single active X chromosome (Xa) in
both males and females in the context of two of each
autosomes [7]. Therefore, Y chromosome erosion and
evolution of X inactivation must have led to a shift in
gene dosage of X-linked genes relative to autosomal
genes. As a consequence, selection pressure to maintain
relative levels of gene products has led to increasing
expression of X-linked genes. Recent evidence suggests
that genes that contribute to multi-component complexes
are most sensitive to changing X:A ratios [8]. The evo-
lutionary progression of the mammalian XY system is
likely complex, with selective forces acting in a hetero-
geneous manner on the many genes located on the X
chromosome. In different mammalian species these
selective forces, which can also include sexually antago-
nistic selection [9], have contributed to different patterns
of gene inactivation, escape from XCI, gene loss, and
translocations [10]. A significant amount of species dif-
ferences has been uncovered in recent studies and has to
be taken into account when extrapolating findings across
mammals.
The mechanism of XCI has most extensively been
studied in the mouse as an accessible model species for
mammalian development. In mice, inactivation of the
paternally inherited X chromosome is initiated at the
4-cell stage. This gives rise to an imprinted pattern of XCI
in the extraembryonic (placental) tissues. At the late
blastocyst stage, reactivation of the Xi is observed in cells
that will form the epiblast. Therefore, two active X
chromosomes (Xa) are observed in the cells of the
developing embryo between embryonic day 4.5 (E4.5)
and E5.5. At the onset of gastrulation, inactivation of
either the paternal or the maternal X chromosome estab-
lishes dosage compensation in embryonic tissues. Once
random X inactivation is initiated, all progeny of the cell
maintain the same pattern of either a maternal or paternal
Xi [7]. This leads to a genetic mosaic of cells with
opposite XCI patterns. It has been estimated that the
embryo contains approximately 200 cells when this
genetic mosaic is established [11]. The presence of cells
with expression from either X chromosome makes female
mammals robust against deleterious mutations on one of
the X chromosomes [12]. This compensation is not pos-
sible in males and a number of X-linked mutations either
lead to lethality in males or can cause diseases [12].
Random XCI has therefore a positive effect on female
fitness in placental mammals, which might be significant,
as maternal fitness is of critical importance in placental
systems [13, 14]. Marsupial mammals possess exclusively
imprinted XCI of the paternal inherited X chromosome
and thus do not benefit from increased female fitness
through XCI mosaicism. It has been argued that imprinted
XCI could be an ancestral form of XCI with the advent of
random XCI as a result of reproductive selective pressure.
However, there is scant evidence in support of this
hypothesis and a parallel evolution of both mechanisms
should be considered equally likely.
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Initiation of chromosome-wide gene silencing
In placental mammals, XCI requires the Xist gene
(Fig. 1a). Xist is located on the X chromosome and is
specifically expressed from the Xi. Its product is a non-
coding RNA that accumulates within the chromosome
territory of the Xi. Xist is required for chromatin modifi-
cations and gene repression on the Xi. Notably, Xist is
specific for placental mammals with no orthologous RNA
described in marsupial mammals or any vertebrate species
to date [15–17]. Recently, the noncoding RNA gene Rsx
(RNA-on-the-silent X) has been identified in marsupials.
Rsx shares some properties with Xist, even though its
sequence is unrelated to Xist [18]. Similar to Xist in pla-
cental mammals, Rsx localizes to the marsupial Xi. It has
further been shown that Rsx expression can cause gene
repression when expressed in mouse cells. This suggests
that Rsx has evolved independently from Xist for the
marsupial dosage compensation system and this case of
convergent evolution might provide opportunities for
studying the function of non-coding RNAs in chromatin
regulation. In mice, Xist expression is regulated by genetic
loci within its surrounding chromosomal locus that is
referred to as the X inactivation center (Xic, Fig. 1b).
Sequences within the Xic provide signals that allow to
establish the number of X chromosomes per cell. It has
been shown that Xic sequences when transgenically trans-
ferred to autosomes can induce X chromosome inactivation
in male mouse ES cells [19, 20]. Deletion of sequences
within the Xic has shown to lead to differential effects.
Deletion of Xist sequences [21–23] results in abrogation of
XCI on the deletion bearing the X chromosome and in
inactivation of the alternative X chromosome. In contrast,
deletions in the 30-region of the Xist gene are associated
with a preferential activation of Xist and inactivation of the
deletion-bearing chromosome [24]. Within this 30 region
lies the promoter and regulatory elements for expression of
the Tsix noncoding RNA (Fig. 1b). Tsix is transcribed in
antisense orientation of Xist [25] and acts as a repressor of
Xist expression [26]. Forced expression of Tsix blocks Xist
expression and XCI [27]. Other noncoding RNAs have also
been implicated in XCI regulation. These include Xite-
derived RNAs [28], Jpx/Enox [29], and Ftx [30]. Xist
expression is also regulated by transcription factors
(Fig. 1c). Binding sites for OCT4, SOX2, and NANOG
within Xist intron 1 have been implicated in repression of
Xist in mouse ES cells [31]. Further binding sites around
the promoter of Tsix are implicated in modulating Tsix
expression and thereby influencing a repressive effect on
Xist [31, 32]. The RNF12 protein is an activator of XCI and
is expressed from a locus with close linkage to Xist. This is
the first candidate protein that has features of a counting
factor for X chromosomes. RNF12 levels correspond to the
probability that a given cell initiates XCI [33–35]. A recent
study links RNF12 to Rex1 [36], a transcription factor that
has been implicated in the expression of Tsix and Xist
regulation, thus, providing a potential mechanism (Fig. 1c;
[37]). In addition, inter-chromosomal pairing of Xic loci
has been implicated in the process of counting the number
of X chromosomes. Two pairing elements have been
described. The Tsix promoter region acts as a pairing ele-
ment when introduced transgenically into mouse ES cells
[38, 39]. A second pairing region is located around the Xpr
region upstream of Xist and is reported to support an
independent and possibly earlier pairing event [40]. The
Xpr region has been shown to be capable of inducing trans-
chromosomal pairing. However, its relevance as an acti-
vator for XCI is debated [33, 41]. It appears that multiple
regulatory input converges on the Xist promoter to ensure
that all but one X chromosomes are inactivated per diploid
genome. Conversely, Xist expression is prevented from the
future Xa.
Once Xist expression is activated, the RNA accumulates
over the Xi chromosome territory and mediates chromatin
modifications (Fig. 1d). Depletion of factors associated
with transcription from the Xi territory are the first changes
that can be detected [42, 43]. These include the loss of
RNA polymerase II and nascent transcripts. Loss of acti-
vating histone marks such as histone H3 lysin 4 tri-
methylation (H3K4me3) and acetylation of histone H3
(H3ac) are followed by a gain in chromatin marks associ-
ated with Polycomb group (PcG) complex activity
(reviewed in [44]). Polycomb repressive complex 1 (PRC1)
mediates mono-ubiquitination of histone H2A lysine 119
(ubH2A) and PRC2 catalyses tri-methylation of histone H3
lysine 27 (H3K27me3) on the Xi. Notably, these changes
in chromatin modifications are not sufficient to cause gene
silencing. It has been shown that chromatin modifications
but not gene repression is effected by expressing a mutant
Xist RNA that lacks sequences on the 50-end [42, 45–47].
The Xist 50 region contains a sequence motif that is con-
served among all placental mammals and has been termed
repeat A element. Seven to eight repeats of a core motif are
separated by a variable spacer [47]. It is presently thought
that Xist repeat A triggers additional pathways for gene
silencing [48], but association with Polycomb group com-
plexes and structural aspects are also discussed [49–51]. In
the presence of repeat A, Xist represses genes and silent
genes associate with the modified chromatin in the center
of the Xi chromosome territory [42]. Thus, a reorganization
of genic chromatin correlates with gene silencing in XCI. If
chromatin reorganization is causal for repression or a
consequence is presently unclear [42, 52, 53].
The Xi chromatin is further modified when cellular
differentiation progresses (Fig. 1d). This involves the
recruitment of additional factors. It has been shown that the
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histone variant macroH2A [54–57], the Trithorax group
protein Ash2L [46], and the scaffold factor SAF-A [46, 58,
59] become enriched on the Xi in differentiated cells. In
addition, DNA methylation of Xi-linked promoters is
established in a manner that depends on SmcHD1 and
Dnmt1 [60, 61]. A number of epigenetic mechanisms act
together to endow gene repression on the Xi with a
remarkable stability. Reactivation of genes on the Xi has
been shown to require the combined interference with
DNA methylation, histone deacetylases (HDACs), and Xist
[23]. Reactivation of genes on the Xi in somatic cells is
heterogeneous and no case of reactivation of the entire
chromosome has been documented. Importantly, Xist is not
critical for gene repression in mouse or human somatic
Fig. 1 The genes involved in
regulation of X inactivation.
a Mouse Xist RNA in interphase
(left) and metaphase (right). Xist
RNA (red) initiates XCI in cis.
b The mouse X inactivation
center (Xic) contains the Xist
gene and regulatory elements.
c The non-coding RNAs Ftx and
Jpx positively regulate Xist
expression, whereas Tsix is a
repressor of Xist and is
transcribed in antisense
orientation over the Xist locus.
Rnf12 is also an activator of Xist
and might exert its function
through targeting the
transcription factor Rex1 for
degradation. Rex1 represses Xist
expression via Tsix-dependent
and -independent mechanisms.
The transcription factors Oct4,
Nanog and Sox2 bind to a site
within Xist intron 1, and are
thought to repress Xist. Tsix
expression is also regulated by
factors in pluripotent cells
including Rex1, YY1 and Ctcf.
Xite has been identified as an
enhancer of Xist that also
produces non-coding
transcripts. d XCI is a complex
process that involves a series of
sequential steps
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cells [62, 63]. Thus far, chromosome-wide Xi reactivation
has only been achieved by reprogramming of somatic cells
to pluripotent stem cells [64].
X inactivation and Xi reactivation in development
A number of studies have provided detailed insight into the
initiation of XCI in mouse embryogenesis (Fig. 2). In mice,
the paternal X chromosome (Xp) is always chosen as Xi
giving rise to imprinted XCI in preimplantation develop-
ment and the extraembryonic lineages. To explain the
difference between the two parental X chromosomes, it has
been proposed that opposing epigenetic marks are
established in the parental germ lines within the Xic.
Embryos with X chromosome aneuploidy have been used
to investigate the nature of these imprinting marks and to
establish whether they originate from oocyte, sperm, or
both. Embryos that inherit a paternal X chromosome (Xp)
but lack a maternal X chromosome (Xm) due to misseg-
regation in oocyte development can survive, indicating that
inactivation of Xp can be prohibited if no Xm is present.
Therefore, the imprint that forces Xp to inactivation is at
least reversible or alternatively is absent altogether [21,
65]. In contrast, if two maternal X chromosomes (Xm) are
inherited from oocytes, XCI is not initiated, resulting in
embryos with two active Xm [66]. This suggests that the
Xm is marked for preventing inactivation and that this
Fig. 2 Dynamic activity of the X chromosome in mouse development.
The unpaired X chromosome is silenced during spermatogenesis by
MSCI. After fertilization reactivation of X-linked genes is observed at
2-cell stage from the paternal X chromosome (1st wave of Xi
reactivation, green arrow). During female preimplantation develop-
ment, the paternal X chromosome becomes inactivated (yellow arrows),
whereby gradual progression of XCI is completed in the developing
extraembryonic lineages (imprinted X-inactivation, red arrows). In
contrast, the paternal Xi is reactivated in cells of the developing epiblast
in the late blastocyst (2nd wave of Xi reactivation, green arrow).
Subsequently, the maternal or the paternal X chromosome is randomly
chosen to be inactivated during embryogenesis (random X-inactivation,
blue arrows). In primordial germ cells (PGCs), Xi is reactivated is
associated with reprogramming of epigenetic patterns including geno-
mic imprinting (3rd wave of Xi reactivation, green arrow). Xi
reactivation occurs before oogenesis is initiated. During the maturation
of oocytes new genomic imprints are established for marking maternal
alleles in the next generation (orange arrows). Therefore, the passage of
the mouse X chromosome through a generation can involve multiple
changes between active and inactive states highlighting periods of
epigenetic reprogramming
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marking is not reversed in early mouse development. The
establishment of an imprint on Xm during oogenesis was
further confirmed by nuclear transfer experiments [67]. The
molecular nature of the imprint on Xm remains to be
defined. Notably, and in contrast to many other imprinted
gene clusters such as Igf2r, Kcnq1, Pws/As, Gnas, Igf2,
Dlk1, and Grb10 [68], DNA methylation is not required for
imprinted Xist expression [69, 70].
During spermatogenesis, unsynapsed X and Y chromo-
somes are silenced through meiotic sex chromosome
inactivation (MSCI) [71] and it has been suggested that the
Xp arrives in a partially silenced state at fertilization. The
absence of nascent transcripts from the Xp territory in
2-cell embryos has been used as an argument for a carry-
over effect of MSCI-mediated Xp silencing through fer-
tilization [72]. These experiments were performed using
repeat-derived RNA in situ hybridization probes that can
identify domains of transcription within both genic and
intergenic regions. Since repetitive elements are largely
absent from coding regions, they preferentially detect
intronic or noncoding transcription but not necessarily
expressed genes. Although some carryover of MSCI can be
detected, it has been shown that MSCI-mediated inactiva-
tion is not required for inactivation in preimplantation
embryos. Okamoto et al. [73] used a YAC transgene, which
contains sequences of the Xic and was integrated into an
autosome. Xist expression of these YAC transgenes was
observed from the paternal genome in extraembryonic
lineages to cause inactivation of the autosomal chromatin.
In this case, MSCI can be ruled out as the transgenic
autosome is normally paired in male meiosis. Further
studies also observed that genes on the Xp become tem-
porary reactivated in 2-cell embryos indicating that the
carryover of MSCI-mediated Xp silencing is only tempo-
rary and might have little effect on genes [73, 74]. A recent
report by Namekawa et al. [75] finds that Xp-linked genes
are temporarily reactivated and subsequently inactivated in
preimplantation development. Taken together, these stud-
ies demonstrate that genes on the Xp are activated in 2-cell
stage simultaneous with the timing of a wave of zygotic
genome activation (EGA) [73, 75]. The mechanism for the
Xp reactivation after fertilization is unclear. However, it
may be linked with the process of repackaging of sperm
DNA into chromatin. In this regard, the recent observation
of Tet3-dependent conversion of 5-methyl cytosine (5mC)
to 5-hydroxymethyl cytosine (5hmC) on the paternal gen-
ome in zygotes might also be of significance [76]. The
differential marking of both parental genomes in the mouse
preimplantation embryo can be expected to influence the
expression of imprinted genes, including Xist.
Genes on Xp are subsequently gradually silenced once
Xist expression is activated. Xist has been observed to
become activated at the 2-cell stage leading to the first
signs of Xp gene silencing around the 4-cell stage.
Thereby, gene silencing appears to be pronounced over
positions close to the Xic [72, 74, 75]. It has been shown
that a deletion of the Xist gene in mice leads to embryonic
lethality after implantation [21, 22]. However, the
requirement of Xist for imprinted XCI before preimplan-
tation of the embryo has been subject to some controversy.
A study by Katalanty et al. [77] observed silencing of genes
on an Xp carrying a deletion of the Xist gene. Furthermore,
Williams et al. showed that Xist depletion in Grb2-/-
blastocysts, which is associated with a wider expression
pattern of Nanog, does not increase the number of blasto-
meres, which showed biallelic expression of X-linked
genes, suggesting that imprinted XCI observed in blasto-
cysts is independently regulated from Xist accumulation
[78]. However, Namekawa et al. [75] observe that Xp
inactivation is controlled by Xist. At present, the discrep-
ancy between these results cannot be easily reconciled as it
appears that the same experimental setup and techniques
resulted in conflicting observations [75, 77]. One inter-
pretation of these findings may be that silencing of some
but not all genes requires Xist [75].
In addition to studies in mice, XCI has also been
investigated in other mammalian species including rabbit
and human preimplantation embryos. This has led to sur-
prising observations of species-specific differences. Xist
expression from both Xm and Xp is observed in rabbit
blastocysts [79], indicating that rabbits might not have
imprinted XCI. In this case, XCI is initiated simultaneously
on both X chromosomes followed by reactivation of one X
chromosome in a random manner. Notably, XIST expres-
sion from both X chromosomes was also observed in a
study of human blastocysts [79]. XIST expression did not
initiate gene repression in human blastocysts and, thus,
XCI appeared to be established only after implantation.
However, these results may need independent confirma-
tion, as earlier work in human preimplantation embryos
reported that XCI is initiated before the blastocyst is
formed in a manner involving upregulation of XIST from
one X chromosome [80]. These discrepancies may reflect
difficulties in obtaining and culturing human preimplanta-
tion embryos. To resolve this issue, an assessment of XCI
in non-human primates might be of high interest. However,
reprogramming of the X chromosomes to an active state
after fertilization similar to autosomes appears a conserved
feature among placental mammals.
Requirement for dosage compensation in the mouse
embryo
In mice, deletion of Xist on the Xp leads to developmental
arrest of female embryos but does not appear to disrupt
preimplantation development. Embryos carrying a
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paternally inherited mutation of Xist develop into cyto-
logically normal blastocysts that can implant [21]. It has
been argued that Xist might not be required for dosage
compensation before implantation [78]. More recent evi-
dence indicates that indeed lack of dosage compensation
can be tolerated for most expressed X-linked genes prior
to implantation [75]. In addition, parthenogenetic blasto-
cysts and haploid mouse embryos have been used for the
establishment of stem cell lines, confirming that lack of
dosage compensation can be tolerated to a large extent in
early embryonic cell types [81, 82]. In the case of haploid
embryos, a relative ratio of X-linked to autosomal (X:A)
gene expression of 1 to 2 cannot be achieved and there-
fore these embryos reflect a non-dosage compensated
state.
In contrast, post-implantation development depends
critically on proper dosage compensation. Embryos carry-
ing a deletion of Xist on the Xp arrest at E7.5 soon after
implantation [21]. This result indicates that inactivation of
the paternally inherited X chromosome is critical for po-
stimplantation development and cannot be compensated by
inactivation of Xm. As a consequence, two X chromo-
somes are active in the extraembryonic lineages and lack of
dosage compensation leads to defects that impair embryo
development. The extraembryonic lineages include the
visceral and parietal endoderm, which are derived from the
primitive endoderm, and parts of the placenta including
trophoblast giant cells, spongiotrophoblast, and syncytio-
trophoblast that are derived from the trophectoderm [83,
84]. Primitive endoderm is thought to be derived from the
hypoblast that is formed from cells of the inner cell mass
(ICM) before reactivation of the paternal Xi is accom-
plished in the blastocyst. Interestingly, parietal endodermal
cells have been established by overexpression of Gata6
gene in mouse ES cells, which showed random X inacti-
vation but not imprinted X inactivation [85]. This result is
consistent with the notion that imprinted XCI in the
primitive endoderm lineage is maintained from preim-
plantation embryos and reactivation might not occur during
normal development.
Repression of Xist on the maternal X chromosome by
Tsix is required for imprinted XCI and development.
Female embryos carrying a mutation of the Tsix gene on
Xm show embryonic lethality owing to ectopic Xist
expression and inactivation of Xm as well as Xp [86]. The
Rnf12/RLIM E3 ubiquitin ligase has been identified as a
dosage-dependent Xist activator [33]. Rnf12 is located on
the X chromosome and appears to regulate imprinted XCI
[35]. It has been observed that the maternal but not
paternal transmission of a mutation in Rnf12 prevents Xist
activation and results in embryonic lethality [35]. Thus, a
mutation of Rnf12 on Xm and a mutation of Xist on Xp
result in defects in imprinted XCI and similar phenotypes
in female embryos [21, 35]. Furthermore, particularly high
levels of RNF12 protein were observed in pronuclei of
zygotes [35], suggesting that maternally deposited RNF12
may contribute to the initiation of imprinted XCI. Nota-
bly, the transmission of the wild-type X chromosome, but
not Rnf12 mutant X chromosome, from Rnf12?/-
oocytes can give rise to normal female offspring at the
expected Mendelian ratio [35]. Therefore, expression of
Rnf12 from maternal X chromosome throughout ovulation
and after fertilization (zygotic activation) are essential for
the activation of Xist expression from the paternal X
chromosome.
Imprinted XCI in mouse development
Imprinted XCI is maintained in the extraembryonic lin-
eages that give rise to the extraembryonic membranes and
contribute to the placenta. Inactivation of genes on the Xp
in these lineages is heterogenous. It has been found that an
Atrx mutation on Xm, a member of the SNF2 family of
ATPase/helicase proteins, leads to escape of the paternally
inherited Atrx gene from imprinted XCI [87]. Escape from
imprinted XCI is not common among other X-linked genes
such as Dkc1, G6PD, and Chm [88–90], indicating that
silencing of the majority of genes on Xp is strictly main-
tained. However, XCI in the extraembryonic lineages
might be less stable than in embryonic lineages. Sponta-
neous reactivation of a GFP transgene has been reported in
a subset of trophoblast giant cells [91] and parietal endo-
derm [27], whereas no reactivation was observed in
embryonic lineages [63]. In contrast to embryonic lineages,
maintenance of Xi silencing requires Xist expression in
trophoblast and parietal endoderm [27]. Furthermore, the
Polycomb group protein Eed is required for maintaining
Xist expression in trophoblast stem (TS) cells [92]. It has
been shown that differentiation of Eed-deficient tropho-
blast stem cells is accompanied by reactivation of genes on
the Xi. However, Eed is not essential for maintaining XCI
in the embryonic lineages suggesting different molecular
requirements between embryonic and extraembryonic cells
[93]. On the contrary, DNA methylation appears to be
essential for maintenance of XCI specifically in the
embryo. Whereas a critical role for Dnmt1 and SmcHD1 in
maintenance of Xi silencing in the embryo has been
established, DNA methylation appears largely dispensable
for imprinted XCI [60, 61]. These observations indicate
that maintenance of XCI depends on different epigenetic
pathways in different cell lineages. Long-term maintenance
of dosage compensation might be less critical in placental
lineages as these are dispensable after birth and the view
emerges that the chromatin configuration of the paternal Xi
in early mouse embryos might be conducive to
reactivation.
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Xi reactivation in mouse epiblast development
The switch from imprinted to random XCI in the mouse
embryo requires the reactivation of genes on the Xp [72,
75, 94]. Reactivation occurs in inner cell mass (ICM) cells
of the blastocyst at E4.5 that give rise to the developing
epiblast lineage. Xp reactivation is accompanied by loss of
Xist expression between the early and late blastocyst stage
[95] followed by loss of H3K27me3, EZH2, and EED from
the Xi [43]. Notably, Williams et al. [78] observed reac-
tivation of genes on the Xp shortly before Xist RNA and
H3K27me3 were lost from the paternal Xi, suggesting that
gene reactivation occurs when Xist and H3K27me3 are
present on the Xi. This observation is at first sight sur-
prising, as an earlier study has shown that Xist is able to
initiate gene repression in ES cells that are derived from
ICM cells [47]. A likely explanation could be that ES cells
do not resemble all aspects of the developing ICM and,
thus, in vivo and in vitro results could be different. Alter-
natively, loss of Xist and H3K27me3 from the chromosome
might be delayed, leading to the detection of residual sig-
nals in few cells in the embryo.
Tsix has been implicated in the switch from imprinted to
random XCI through inducing efficient H3K4 methylation
over the entire Xist/Tsix unit for equalizing and resetting
the epigenetic status on both Xic alleles [96]. It has been
shown that transient induction of Tsix expression from Xp
in blastocysts represses Xist and leads to Xp reactivation
[27]. However, Tsix induction does not induce a switch
from imprinted to random XCI in the extraembryonic lin-
eages and when Tsix expression is terminated inactivation
of the same X chromosome is restored. This result indicates
that additional steps are required for resetting the imprint
on Xm for switching to random XCI.
The transcription factors OCT4 (official gene nomen-
clature Pou5f1, also called Oct3/4), SOX2, and NANOG
have been proposed to repress Xist when pluripotency is
established [31]. These three factors bind to a site within
Xist intron 1. Consistent with a role in Xist repression, it
has been shown that the loss of OCT4 or NANOG leads to
activation of Xist expression in mouse male ES cells.
However, a genetic deletion of the binding site within Xist
intron 1 does not result in a similarly strong effect on Xist
expression suggesting that other regulators might also be
involved [34]. In line with this finding, a combined deletion
of the intron 1 binding site and Tsix has been observed to
enhance Xist upregulation suggesting a synergistic effect
[97]. Even though intron 1 element is not absolutely
required for repressing Xist in ES cells, it may still function
in switching imprinted to random XCI in the embryo.
Future work will be crucial to investigate whether blasto-
cysts carrying a paternal deletion of the intron 1 element
have defects in resetting imprinted XCI. Recent work has
shown that RNF12 regulates the protein level of REX1 that
has been implicated as a transcription factor for the acti-
vation of Tsix [36, 37]. These findings might provide an
additional link between XCI and the transcription network
of pluripotent cells. Notably, Rex1 expression is rapidly
lost when ES cells enter differentiation and, thus, correlates
negatively with XCI, suggesting that reduced activation of
Tsix through loss of REX1 might contribute to the initiation
of XCI.
In conclusion, reactivation of the Xi in the ICM appears
to be tightly linked to the establishment of pluripotency.
Imprinted XCI appears not to be stable at this stage, and
might be readily reversible following loss of Xist expres-
sion and chromatin modifications [27, 98]. However, ES
cells can also reactivate a somatic Xi, indicating that the
chromatin environment of pluripotent cells facilitates
changes of epigenetic states. This observation is in line
with reports of a more dynamic chromatin structure and
particular chromatin modifications associated with active
chromatin in mouse ES cells [99, 100]. Reactivation of
imprinted XCI might be mediated by a combination of a
reversible chromatin structure on the paternal Xi and active
mechanisms that remodel silent chromatin and repress Xist.
Establishment of XCI in the developing mouse embryo
Following the reactivation of paternal X chromosome in
epiblast lineages, either the maternal or paternal X chro-
mosome is randomly chosen to be inactivated. A number of
studies have contributed to an understanding of the
mechanism of choosing the Xi (reviewed in [44]). Xist
expression from maternal X chromosome is first observed
at E5.5, suggesting the initiation of random XCI [94].
Formation of Xi heterochromatin has been investigated in
the mouse embryo using different cytological methods.
Rastan et al. [101] showed that an Xi could be observed in
E7.0 epiblast using Kanda’s method, which visualizes Xi as
a dark-stained chromosome. Similarly, Takagi et al. [102]
concluded that an Xi could already be observed in E6.5
embryos taking advantage of late replication as a marker of
the Xi. Consistent with this timing of XCI, a limited
number of X-linked genes, including Hprt and Pgk1 as
measured by their enzymatic activity, are also silenced on
the Xi in E6.5 and E7.0 embryos, respectively [11, 103]. In
addition, DNA methylation of the Pgk1 promoter on the Xi
is observed around E7.0 [104]. Silencing of Pgk1 and
establishment of DNA methylation on the Pgk1 promoter
occur simultaneously, whereas DNA methylation of the
Hprt promoter is first observed at E13.5, which is a con-
siderable amount of time after Hprt silencing is observed at
E6.5 [105]. This finding suggests that initially Hprt
repression is largely independent of DNA methylation
before E13.5. Taken together, these studies indicate that
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dosage compensation is established by E6.5 in the female
mouse embryo.
Several factors have been investigated for a potential
role in the maintenance of gene repression on the Xi in
later embryos (reviewed in [44]). The SmcHD1 (structural
maintenance of chromosomes hinge domain containing 1)
protein localizes to the Xi and is required for the mainte-
nance of gene silencing on the Xi [60]. It has been shown
that genes on the Xi become activated in SmcHD1-deficient
embryos. In addition, DNA methylation is lost on pro-
moters of some genes on the Xi. This is further consistent
with a requirement for the DNA methyltransferases Dnmt1
for maintaining gene silencing on the Xi [61]. Although
Polycomb group (PcG) complexes are recruited to the Xi,
their role in maintaining silencing remains to be clearly
established. Recruitment of PcG proteins appears to be
largely dependent on Xist [106, 107], which is required for
initiation but not for maintenance of the Xi in differentiated
cells [62, 98]. These observations indicate that most PcG
proteins that have been studied thus far at the Xi might
actually not be essential for maintaining random XCI.
However, it is conceivable that other components or spe-
cific chromatin structures are established through PcG
complexes that are maintained in the absence of Xist and,
thus, could facilitate maintenance of XCI. Xi reactivation is
observed when a genetic disruption of Xist is combined
with chemical inhibition of DNA methylation and histone
deacetylation with 5-aza deoxycytosine (5-azadC) and
Trichostatin A (TSA), respectively [23]. This observation
suggests that multiple epigenetic mechanisms contribute to
gene repression on the Xi in somatic cells. Reported
attempts for gene reactivation by interference with these
mechanisms generally lead to reactivation of a small
number genes in a small percentage of cells, indicating that
loss of repression on the Xi can be induced in a stochastic
but not a chromosome-wide manner. Chromosome-wide Xi
reactivation has to date been achieved through repro-
gramming of somatic cells to induced pluripotent stem
cells (iPS cells).
Xi reactivation in primordial germ cell development
In mice, primordial germ cells (PGC) can be first identified
at E7.5 in a posterior position of the epiblast. PGCs orig-
inate from the epiblast that has already initiated random
XCI and migrate to the genital ridge by E10.5 (reviewed in
[108]). During this migration, epigenetic modifications are
reprogrammed and the Xi is reactivated before sex-specific
differentiation of the germline is initiated at E12.5. A series
of experiments have defined the timing of Xi reactivation
in PGC development using single-cell PCR- and PGC-
specific markers [109–111]. These investigations have led
to the conclusion that Xi reactivation is initiated during the
migration of PGCs towards the genital ridge. Thereby,
reactivation proceeds in a gradual manner over a consid-
erable developmental interval. The effect of Xi reactivation
is that both X chromosomes in female PGCs are in an
active state before oogenesis is initiated.
The mechanisms of Xi reactivation in PGC development
has attracted considerable interest and has been investigated
by a number of studies. Logically, it can be divided into
several steps: repression of Xist expression, loss of Xi
marker H3K27me3 accumulation, and reactivation of
X-linked genes from Xi. Reactivation of genes on the Xi
appears to be a gradual process that also temporally over-
laps with phases of DNA demethylation and changes in
chromatin modifications that are associated with genome-
wide reprogramming of PGCs [108]. Interestingly, the
timing of the initiation of Xist repression and Nanog
expression appears to overlap in E7.5 PGCs [112] similar to
the ICM, when Nanog is required for the establishment of
pluripotency [113]. Repression of Xist expression from
imprinted paternal Xi is observed in NANOG-positive cells
of the ICM [94]. Furthermore, NANOG expression is cor-
related with Xi reactivation and Xist repression at the
transition from pre iPS cells to iPS cells [114]. Taken
together, Nanog expression may be a candidate for factors
contributing to Xist repression in PGCs, similar to the role
of pluripotency factors for Xist repression in the ICM has
been proposed [31]. Loss of H3K27me3 from the Xi may be
explained as a consequence of loss of Xist expression, since
it has been shown that PcG recruitment depends on Xist in
ES cells [45, 106]. However, it remains to be elucidated
whether Xist repression is actually required for Xi reacti-
vation in PGCs. A number of epigenetic modifications,
including H3K9me2, H3K27me3, H2A/H4R3me2s, and
DNA demethylation, undergo prominent changes during
PGC development and are thought to mediate reprogram-
ming of the germline genome [108]. In addition, DNA
demethylation is observed. This makes PGC development
an interesting system for analyzing epigenetic processes
and the mechanistic understanding of Xi reactivation.
Exploring the mechanism of Xi reactivation
In mice, three distinct developmental stages are associated
with Xi reactivation. The paternal X chromosome is reac-
tivated in the oocyte after fertilization and thereby MSCI is
reversed. Following imprinted XCI in preimplantation
development, Xi reactivation is observed in the developing
epiblast at E4.5. Finally, in migrating PGCs, Xi reactiva-
tion establishes two active X chromosomes in female germ
cells before oogenesis. During this process, genomic
imprinting is erased, whereas imprints are maintained
through fertilization and epiblast development (Table 1).
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The mechanisms of Xi reactivation during these cell
reprogramming episodes remain to be elucidated. It will be
important to establish if common pathways can be identified
or entirely different pathways are used at specific develop-
mental stages. For addressing reprogramming mechanisms,
different experimental systems have been developed
(Table 2). Xi reactivation is recapitulated during nuclear
cloning [115], cell fusion with pluripotent cells [116], and
iPS cell generation through the expression of pluripotency
factors (Fig. 3; Table 2; [117]). In addition, genetic and
chemical screens have been applied for identification of
factors that lead to reactivation of genes on the Xi.
Triggering Xi reactivation by nuclear transplantation
into oocytes
Transplantation of cell nuclei into oocytes of frogs and
mammals has been used to reset the developmental
potential of embryonic and somatic cells for producing
cloned animals [118–120]. A somatic nucleus transferred
into enucleated oocytes can recapitulate the reprogram-
ming process observed in a fertilized egg. Analysis of XCI
in cloned mice has shown that if a somatic donor cell is
used, the donor cell’s Xi is chosen for inactivation in
extraembryonic tissues of cloned embryos similar to
imprinted inactivation of the paternal X chromosome in
embryos obtained from fertilization [115]. In the embry-
onic cells of cloned mice random XCI is observed
suggesting normal reactivation followed by random XCI in
the epiblast can be accomplished. Notably, if female ES
cells that possess two active X chromosomes are used as
nuclear donor, random XCI is also observed in the extra-
embryonic tissues of cloned mice [115]. This observation
indicates that a counting mechanism for random XCI or
stochastic choice can substitute in the extraembryonic
lineages for an imprint or pre-determined inactivation state.
This is further consistent with the development of parthe-
nogenetic and androgenetic female embryos that possess
exclusively either maternal or paternal X chromosomes.
Furthermore, the kinetics of Xi reactivation in cloned
embryos, as observed using an X-linked GFP transgene, is
consistent with physiological Xi reactivation in normal
embryogenesis [115]. Changes in histone modifications
[121] and DNA demethylation [122] have been studied in
nuclear transfer embryos. These studies suggest that subtle
differences exist possibly owing to technical limitations or
different donor cell states. However, the observations
suggest that cloning recapitulates reprogramming of the
zygotic genome in fertilized egg development to a large
extent. Recently, the role of the Tet3 enzyme for hydrox-
ymethylation of DNA of the paternal genome has been
demonstrated [76]. This might be one of several mecha-
nisms that mediate reprogramming of the genome after
fertilization. A major difference between the genomes in
sperm and in somatic cells is their packaging into chro-
matin. The sperm genome is re-packaged into chromatin
after fertilization and might be more accessible for modi-
fications in the zygote than a genome transferred into the
oocyte from somatic cells.
Nuclear transfer in mammals is an inefficient process
owing to erroneous reprogramming of the donor genome.
Incomplete erasure of epigenetic information from somatic
cells, genetic aberrations and technical problems with
embryo viability are key factors to consider. In addition,
down-regulation of X-linked genes is observed in both
male and female cloned mouse embryos. This has been
linked to an inappropriate activation of Xist and the initi-
ation of XCI. Notably, the efficiency of mouse cloning is
significantly improved when nuclear donor cells bearing a
deletion of Xist are used [123]. The reason why Xist is
ectopically expressed in nuclear transfer embryos is not
entirely clear. One reason could be that the Xist promoter is
in a configuration in somatic cells that leads to activation
during reprogramming. Alternatively, indirect effects could
lead to Xist activation such as ectopic RNF12 expression.
The use of siRNAs against Xist has further been shown to
be useful for improving cloning efficiency in mice sug-
gesting a potential application for clone production [124].
Xi reactivation has been also studied using Xenopus
oocytes as reprogramming environment [125]. Since frogs
do not possess an XCI mechanism, these cross-species
experiments are harder to interpret but can be useful for
addressing specific questions. Interestingly, the ability to
reactivate Xi by nuclear transfer to frog eggs appears to be
restricted by the developmental state of the donor nuclei.
The Xi of epiblast stem cells (EpiSCs) and ES cells is
reactivated upon transfer into frog eggs. In contrast, the Xi
of embryonic fibroblasts or extraembryonic cells cannot be
reactivated in the frog reprogramming system. Analysis of
Xi chromatin composition has led to the suggestion that the
histone variant MacroH2A could contribute to inhibition of
reactivation in Xenopus oocytes. MacroH2A is enriched on
the Xi of fibroblast and extraembryonic cells but is absent
from the Xi in ES cells and EpiSCs. Conversely, depletion
of MacroH2A in MEFs by RNA interference enhances Xi
reactivation after transfer into frog eggs to some extent.
This finding suggests that macroH2A contributes to the
stability of the Xi but additional factors are also involved.





X reactivation in oocyte Totipotency Maintained Maintained
X reactivation in epiblast Pluripotency Erased Maintained
X reactivation in PGC Unipotency – Erased
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Xenopus oocytes provide a biochemical system for under-
standing reprogramming and might be useful for
understanding certain aspects of Xi reactivation. Several
factors have been implicated in reprogramming including
Nucleoplasmin [126], histone H1 [127], and nuclear actin
[128]. Future studies will need to establish to what extent
reprogramming in Xenopus and mouse oocytes is
conserved.
Xi reactivation by fusion with pluripotent cells
Pluripotent stem cells have been derived from preimplan-
tation embryos or germ cell tumors. Embryonic carcinoma
(EC) cells are derived from teratocarcinomas and resemble
some aspects of pluripotency, as they can differentiate into
cell types of the three germ layers when transplanted into
immunodeficient mice. It has been observed that fusion of
somatic cells with EC cells can induce reactivation of the
Xi of the somatic cell [83]. Analogous experiments have
also been carried out with mouse ES cells [116, 129].
These observations are a powerful demonstration of the
capability of mouse ES cells that not only carry two active
X chromosomes but also possess the pathways to reactivate
an Xi of somatic cells. The specific chromatin environment
in pluripotent cells, such as EC or ES cells, appears to
permit reprogramming of epigenetic patterns of the somatic
genome.
For understanding the molecular basis of this repro-
gramming ability, the genetic requirements for
reprogramming of somatic cells by mouse ES cells have
been investigated. Initial studies have shown that the de
novo DNA methyltransferases Dnmt3a and Dnmt3b,
Dnmt1, as well as the chromatin factors Mll, G9a, Jarid2
and the nuclease Dicer are not required for reprogramming
the somatic cell genome by ES cell fusion [130]. In con-
trast, the Polycomb proteins EED and SUZ12 are required
for reprogramming by the ES cell fusion partner [130].
Notably, the defect in reprogramming cannot be compen-
sated by an additional normal ES cell fusion partner,
indicating that Eed-deficient ES cells exert a dominant
effect and inhibit reprogramming [130]. It has been sug-
gested that this inhibition could be caused by the
expression of genes that are normally repressed by Poly-
comb activity and interfere with critical steps in
reprogramming the somatic cell. It has been observed that
although Eed is not essential for ES cell survival, it
nonetheless leads to aberrant gene expression and a com-
promised phenotype [107]. This could suggest that
reprogramming of somatic cells depends on a stable
nuclear phenotype of pluripotent cells.
Fig. 3 Cellular systems
recapitulating Xi reactivation.
a Mouse female ES cells
possess two active X
chromosomes. Upon
differentiation, random XCI is
initiated. b Reactivation of the
Xi of mouse somatic cells can
be achieved by a number of
experimental manipulations. Xi
reactivation is recapitulated
during somatic cell nuclear
transfer into oocytes, cell fusion
with pluripotent cells such as
mouse ES cells and EG cells,
and iPS cell reprogramming
2454 T. Ohhata, A. Wutz
123
In addition to fusion of somatic cells with ES or EC
cells, fusion with embryonic germ (EG) cells has also been
shown to induce reprogramming of the somatic cell gen-
ome. EG cells can be established from PGCs and are
maintained in culture as cell lines with similar morphology
and differentiation potential as mouse ES cells. During
PGC development, Xi reactivation is also accompanied by
the erasure of genomic imprints, which makes the germ
lineage a unique reprogramming system (Table 1). It has
been shown that fusion of somatic cells with EG cells
induces Xi reactivation and in addition leads to a loss of
DNA methylation patterns associated with the control of
imprinted genes [131]. In contrast, genomic imprinting is
largely maintained in fusion products of somatic cells with
mouse ES cells [129] or embryonal carcinoma (EC) cells
[132]. These observations suggest that EG cells possess an
extended reprogramming capability that has triggered
interest in defining the molecular basis of these repro-
gramming pathways. In this regard, a recent study
reporting the generation of PGC-like cells (PGCLCs) from
ES cells is of considerable importance. PGCLCs can give
rise to functional sperm when transplanted into the genital
ridge of host embryos [133]. This in vitro system is
promising to define the molecular basis of PGC develop-
ment and the mechanism of epigenetic reprogramming.
Taken together, a number of studies have illustrated the
application of cell fusion to gain insight into epigenetic
reprogramming associated with cell-type changes. How-
ever, these types of experiments also have limitations. Cell-
fusion experiments produce tetraploid cells that might
differ from normal diploid cell types. This concern has to
be considered for the interpretation of cell-fusion
experiments.
Xi reactivation during reprogramming of induced
pluripotent stem cells
Expression of the four transcription factors OCT4, KLF4,
SOX2, and c-MYC can reprogram somatic cells to a plu-
ripotent state, thereby establishing an iPS cell line [134]. It
has been shown that Xi reactivation occurs at a late stage in
the reprogramming process of mouse cells after the
endogenous Oct4 promoter is activated [64]. Since any cell
type can be reprogrammed to an iPS cell-like state, recent
studies have focused on closely related cell types for
understanding the trigger for Xi reactivation. It has been
shown that pre-iPS cells that are trapped in an intermediate
state of reprogramming can be converted to iPS cells by
using a defined medium [114]. In this system, a rapid
transition to fully reprogrammed iPS cells occurs with high
frequency and is accompanied by reactivation of the Xi
from the pre-iPS cells to an active X chromosome in iPS
cells. Similarly, the transition from mouse EpiSCs to ES
cells can be accomplished by expressing Klf4 and is
accompanied by Xi reactivation [135]. Analysis of these
transitions facilitates the molecular characterization of
changes that correlate with Xi reactivation. Since Oct4 and
Sox2 are expressed in EpiSCs [135], it is unlikely that they
have a critical role in triggering Xi reprogramming.
Although Nanog is expressed in EpiSCs, overexpression of
Nanog leads to conversion to iPS cells and Xi reactivation
[113]. In addition, REX1 expression is specific for ES cells
and could therefore be a factor in either Xist repression or
Xi reactivation [136].
It is still unclear if Xist repression during reprogram-
ming is required or a correlative effect of the
reprogramming process. Reprogramming in human cells
and reprogramming of mouse somatic cells to EpiSCs
[137] does not involve reactivation of the Xi. In both cases,
pluripotent cells are generated, suggesting that induction of
a pluripotent developmental potential does not require Xi
reactivation. However, Xi reactivation might indicate a
chromatin environment that makes reprogramming more
efficient or complete. Recently, Xi reactivation in human
iPS cells has been reported. When female human somatic
cells are reprogrammed by expression of OCT4, KLF4, and
KLF2 in culture conditions including LIF and inhibitors of
GSK3 and ERK kinase activity iPS cells with two active X
chromosomes can be obtained [138]. Similar results were
obtained with ectopic expression of six factors (OCT4,
SOX2, KLF4, c-MYC, RAR-c, and LRH-1) in medium
containing LIF and GSK3 and MEK inhibitors [139]. In
addition, pre-XCI human ES cells were established from
embryos in medium containing LIF in physiological oxy-
gen atmosphere [140]. These ‘‘naive’’ human pluripotent
cells may improve the quality of therapeutic research and
regenerative medicine. Furthermore, they might provide a
model for studying XCI and Xi reactivation in humans. Xi
reactivation could thereby be useful for selecting human
ES and iPS cells of different qualities from female donors.
Studies of genomic reprogramming in PGCs have
identified additional factors that are linked to epigenetic
reprogramming not only of the Xi but also of genomic
imprints. Prdm14 encodes a PR domain-containing tran-
scriptional regulator that is highly expressed during PGCs
development and has a critical role for the establishment of
the germ line. Prdm14 is required for Sox2 upregulation
during epigenetic reprogramming in PGCs [141]. Although
weak and transient Prdm14 expression is observed in
blastocyst, Prdm14 might not be required for maintaining
pluripotency in ICM since Prdm14 mutant mice develop
normally except for defects in the germ cell lineages [141].
Recently, Gillich et al. [142] have reported that the over-
expression of Prdm14 and Klf2 in mouse EpiSCs can
induce highly efficient conversion to ES cells and trigger
Xi reactivation. These results indicate that factors
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identified in germ cell development might be useful for
reactivating the Xi and also for enhancing the reprogram-
ming process. Culture systems that allow manipulating the
developmental state of cells such as ES cells, PGCs, and
EpiSCs will be essential for understanding the molecular
pathways for reprogramming epigenetic patterns in the
future.
Reactivation of genes on the Xi in development
and disease
Xi reactivation is also observed in a small number of cells
in the mouse extraembryonic lineages, including tropho-
blast giant cells [91] and parietal endoderm cells [27]. If Xi
reactivation at these stages is developmentally controlled
or represents stochastic events that lead to a failure of XCI
maintenance is unclear at present. It further needs to be
investigated if reactivation occurs chromosome-wide in
these cases. In a mouse model for inducible Tsix expres-
sion, the number of cells that reactivate the Xi has been
increased several-fold by forced repression of Xist [27].
Similarly, a mutation of Eed causes the loss of Xist and Xi
silencing in the developing trophectoderm [143]. These
observations could suggest that loss of dosage compensa-
tion can be induced and is tolerated in extraembryonic
tissues of the mouse. In contrast to extraembryonic lin-
eages, Xi reactivation is not observed in embryonic cell
types. A combination of Xist deletion, DNA demethylation,
and histone deacetylation increases the frequency of Xi
reactivation in primary mouse embryonic fibroblasts [23].
Reactivation is gene-specific and likely reflects stochastic
events. This has been inferred from analyzing clones of
fibroblast where individual X-linked genes have been
reactivated but other genes remained silenced [23]. A
screen based on a targeted siRNA library has identified
several candidate genes that are involved in the mainte-
nance of XCI in somatic cells. Interference with the
expression of the origin recognition complex 2 (Orc2) and
heterochromatin protein 1 (HP1a) genes has been shown to
lead to derepression of genes on the Xi [144]. Orc2
encodes a general factor for DNA replication, thus, having
additional roles in cell division. HP1a is associated with
pericentric heterochromatin in the mouse and has also been
observed on the Xi in some human cell lines [145]. RNA
interference experiments have further implicated mac-
roH2A1 and Bmi1 as factors for XCI maintenance [146].
Mutation of macroH2A1 is compatible with normal
development and female mice are healthy and fertile [147].
This finding suggests that macroH2A1 is not essential for
XCI and could indicate that other factors could compensate
for mutation of macroH2A1 in development. Similarly, a
mutation of Bmi1 is compatible with female embryo
development precluding an essential role in XCI [148].
These observations suggest that a number of factors affect
the stability of gene silencing on the Xi but future work
will be needed to elucidate the entire chromatin configu-
ration that underlies XCI maintenance in somatic cells.
Mouse cells with reporter genes on the Xi are a valuable
tool for performing chemical screens for identifying mole-
cules that induce Xi reactivation. These screens could be
useful for identifying compounds with activity towards
chromatin modifying or regulatory factors. Xi reactivation
could thus provide a powerful system for studying chromatin
remodeling and reprogramming. Potential applications for
Xi reactivation are human diseases that are caused by gene
mutations on the X chromosome. In principle, reactivation of
the intact copy of the gene from the Xi in female patients
could remedy the genetic defect. Ideally, this treatment
would be gene-specific and targeted to the relevant cell types.
However, the observation that differentiated cell types can
tolerate loss of dosage compensation at least in extraem-
bryonic tissues could also encourage chromosome-wide
reactivation approaches. Reactivation of the MeCP2 gene
from the Xi has been proposed as a potential strategy for
helping RETT syndrome patients [149]. RETT syndrome is a
neurodevelopmental disorder that has a late onset in female
patients [150]. In mice, a neurodevelopmental defect can be
recapitulated by a MeCP2 mutation [151]. Importantly,
restoration of MeCP2 function in MeCP2-deficient mice
alleviates the neuronal phenotype [149], suggesting that
restoration of MeCP2 could also help ameliorate symptoms
in RETT syndrome patients. Xi reactivation could be applied
to a number of X-linked human diseases [12]. However,
these approaches need to be carefully considered. Effective
treatments for reactivation of the Xi are likely correlated with
widespread disruption of epigenetic patterns elsewhere in the
genome that could cause adverse effects. Even if side-effects
are not immediate, impaired epigenetic regulation could
have long-term effects and could lead to problems associated
with stem cell maintenance or cell transformation. Further
studies are therefore needed before such approaches can be
adopted in the clinic. Considerations of limiting potential
treatments to certain tissues or cell types are important.
Although more work is required, Xi reactivation approaches
could avoid genetic transformation with expression vectors
for the defective genes and thus offer an exciting and com-
plementary opportunity to existing strategies.
Loss of the Xi or reactivation of the Xi has also been
associated with certain human tumors. In BRCA1-deficient
breast tumors, a loss of the Xi and gain of an Xa has been
observed [152, 153]. In a subset of tumors, reactivation of
the Xi has been suggested as the likely cause. Elevated X:A
dosage also accompanies strongly hypoploid tumor cells
associated with rare human tumors ([154] and references
therein). Presently, it is unclear if X-linked gene expression
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is selected for in certain tumors or if these observations are
made as a consequence of drift of the tumor karyotype.
Intriguingly, multiple X chromosomes are also reported in
cases of testicular germ cell tumors [155]. These tumors
appear to possess predominantly hypomethylated and
active X chromosomes irrespective of XIST expression.
The accumulation of multiple X chromosomes in these
tumors has further been linked to expression of the
X-linked oncogenes ARAF1 and ELK1 [155]. Taken
together, these observations suggest that dosage compen-
sation can be dynamic in certain tumors and XCI could be
furthermore useful for tumor diagnosis in some instances.
Concluding remarks and future outlook
The X chromosome undergoes repeated inactivation and
reactivation during development. Reactivation of genes on
the paternal X chromosome is observed in the fertilized
oocyte. In the mouse, reactivation of the Xi in the developing
epiblast follows imprinted inactivation in preimplantation
embryo. In other mammals that do not have imprinted XCI,
XCI might not be initiated before the blastocyst is formed
and, hence, Xi reactivation is not required. This could also be
the case in humans, but more work is needed to confirm this
interpretation. During development of the female germline,
Xi reactivation overlaps with a period of migration and
genome-wide reprogramming in PGCs. Understanding of
the mechanism of Xi reactivation could be applied for
developing therapeutic strategies to cure genetic diseases
that involve mutations in X-linked genes such as muscular
dystrophy and RETT syndrome [149]. Cell culture models
such as iPS cell reprogramming or cell fusion with ES cells
provide opportunities for studying Xi reactivation. Immense
progress in understanding the mechanism has been made in
recent years but several questions remain to be addressed in
the future.
A critical question is what the requirement for Xi
reactivation is. In the mouse, dosage compensation is lost
in the developing epiblast between E4.5 and E6.5 and
could lead to differences in relative gene expression
between male and female embryos. It will be interesting to
analyze if Xi reactivation in the epiblast reflects a special
epigenetic environment linked to the pluripotency of the
cells. Although dosage compensation is required for female
development, it appears that XCI and X:A ratios are critical
only at certain developmental states. Aneuploidy involving
X chromosomes is tolerated in cell culture and might even
be selected for in tumors. It is not clear at the moment if the
requirement for XCI involves very specific and sensitive
stages in embryo development or is a general requirement
for differentiated tissue cells. Accumulation of X
chromosomes in certain tumors seems to be linked to
oncogenic signals. These observations could provide an
opportunity to understand drivers of tumor development
that have, thus far, not been extensively studied. Recent
analysis has identified dosage-sensitive genes on the X
chromosome in mice [8]. This group of genes is precisely
balanced between males and females and contains com-
ponents of large protein complexes. These genes might
contribute to pathways that either act at specific develop-
mental stages or that are essential only at certain critical
developmental events. Future studies of the cause and the
consequences of Xi reactivation in different cell systems
will advance our understanding of epigenetic regulation
and genome evolution in mammals. This is important as
several aspects of mammalian dosage compensation
emerge to have clinical implications and could be useful
for diagnosis and potential therapeutic strategies.
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